A comparison of factors associated with prevalent diabetes mellitus among HIV-infected antiretroviral-naive individuals versus individuals in the national health and nutritional examination survey cohort

被引:44
作者
Brar, Indira
Shuter, Jonathan
Thomas, Avis
Daniels, Eric
Absalon, Judith
机构
[1] Henry Ford Hosp, Div Infect Dis, Dept Med, Detroit, MI 48202 USA
[2] Montefiore Med Ctr, Dept Med, Div Infect Dis, New York, NY USA
[3] Univ Minnesota, Dept Biostat, Minneapolis, MN USA
[4] Social & Sci Syst, Silver Spring, MD USA
[5] Columbia Univ Coll Phys & Surg, Harlem Hosp Ctr, Div Infect Dis, New York, NY 10032 USA
[6] Columbia Univ, Dept Epidemiol, New York, NY USA
关键词
antiretroviral naive; diabetes; diabetes mellitus in antiretroviral-naive HIV-infected patients; HIV; racial/ethnic minorities; women;
D O I
10.1097/QAI.0b013e318031d7e3
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: in the general population, diabetes mellitus (DM) is associated with age, minority race/ethnicity, and obesity. Among HIV-infected persons, antiretroviral therapy (ART) use and hepatitis C virus (HCV) infection have been associated with DM. This study examined DM prevalence and its predictors in ART-naive HIV-infected patients. Methods: A cross-sectional analysis of ART-naive HIV-infected adults enrolled in 3 Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) clinical trials versus adults enrolled in the National Health and Nutritional Examination Survey (NHANES). Results: The prevalence of DM in the CPCRA clinical trials versus the NHANES was 3.3% versus 4.8%. The mean body mass index (BMI) was lower in the CPCRA trials versus the NHANES (25 kg/m(2) vs. 28 kg/M-2). HCV was associated with DM only in univariate analyses in the CPCRA trials. In univariate and multivariate analyses, race/ethnicity, age, and BMI were associated with DM in both cohorts. Among women, age and BMI were associated with DM in both cohorts;, race/ethnicity was associated with DM only in the NHANES. HCV was predictive of DM in blacks in the CPCRA trials (P = 0.004 before adjustment for multiple comparisons) but not in the full cohort. Conclusions: Our findings did not suggest an increased prevalence of DM in ART-naive HIV-infected patients. Although there was a trend toward increased prevalence of DM in HIV-HCV-coinfected patients, dominant risk factors associated with DM among ART-naive HIV-infected adults mirrored those of the general population.
引用
收藏
页码:66 / 71
页数:6
相关论文
共 25 条
[1]   Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors [J].
Behrens, G ;
Dejam, A ;
Schmidt, H ;
Balks, HJ ;
Brabant, G ;
Körner, T ;
Stoll, M ;
Schmidt, RE .
AIDS, 1999, 13 (10) :F63-F70
[2]   Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the Multicenter AIDS Cohort Study [J].
Brown, TT ;
Cole, SR ;
Li, XH ;
Kingsley, LA ;
Palella, FJ ;
Riddler, SA ;
Visscher, BR ;
Margolick, JB ;
Dobs, AS .
ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (10) :1179-1184
[3]   Risk of diabetes in HIV infected veterans pre- and Post-HAART and the role of HCV coinfection [J].
Butt, AA ;
Fultz, SL ;
Kwoh, CK ;
Kelley, D ;
Skanderson, M ;
Justice, AC .
HEPATOLOGY, 2004, 40 (01) :115-119
[4]  
Cardinal H, 2004, CAN J CARDIOL, V20, P417
[5]   HIV lipodystrophy: risk factors, pathogenesis, diagnosis and management [J].
Carr, A .
AIDS, 2003, 17 :S141-S148
[6]   Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study [J].
Carr, A ;
Samaras, K ;
Thorisdottir, A ;
Kaufmann, GR ;
Chisholm, DJ ;
Cooper, DA .
LANCET, 1999, 353 (9170) :2093-2099
[7]  
*CDCP, 2003, MMWR-MORBID MORTAL W, V52, P833
[8]  
Dever LL, 2000, ANN PHARMACOTHER, V34, P580
[9]   Combination antiretroviral therapy and the risk of myocardial infarction [J].
Friis-Moller, N ;
Sabin, CA ;
Weber, R ;
Monforte, AD ;
El-Sadr, WM ;
Reiss, P ;
Thiébaut, R ;
Morfeldt, L ;
De Wit, S ;
Pradier, C ;
Calvo, G ;
Law, MG ;
Kirk, O ;
Phillips, AN ;
Lundgren, JD ;
Lundgren, JD ;
Weber, R ;
Monteforte, AD ;
Bartsch, G ;
Reiss, P ;
Dabis, F ;
Morfeldt, L ;
De Wit, S ;
Pradier, C ;
Calvo, G ;
Law, MG ;
Kirk, O ;
Phillips, AN ;
Houyez, F ;
Loeliger, E ;
Tressler, R ;
Weller, I ;
Friis-Moller, N ;
Sabin, CA ;
Sjol, A ;
Lundgren, JD ;
Sawitz, A ;
Rickenbach, M ;
Pezzotti, P ;
Krum, E ;
Meester, R ;
Lavignolle, V ;
Sundström, A ;
Poll, B ;
Fontas, E ;
Torres, F ;
Petoumenos, K ;
Kjær, J ;
Hammer, S ;
Neaton, J .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (21) :1993-2003
[10]   An association between HIV/HCV co-infection and diabetes mellitus - is there a need for routine blood glucose monitoring? [J].
Hamill, M ;
Brook, G .
JOURNAL OF CLINICAL VIROLOGY, 2005, 33 (02) :176-178